PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$28.72M
Total Shares
18.17M
Net Share Change
+721.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Patient Capital Management
$28.72M18.17M shares
ADD+721.2K(+4.1%)